14q11.2 microduplication syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:261229Q92.3
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

14q11.2 microduplication syndrome is a rare chromosomal anomaly caused by a small duplication of genetic material on the long arm of chromosome 14 at the 11.2 band region. This condition is classified under chromosomal duplications (ICD-10: Q92.3) and is characterized by variable clinical expression, which can make diagnosis challenging. The duplicated region may encompass several genes, and the clinical consequences depend in part on the size of the duplication and the specific genes involved. The syndrome primarily affects neurodevelopmental and cognitive functions. Key clinical features reported in affected individuals include intellectual disability of variable severity, developmental delay (particularly speech and language delay), and behavioral abnormalities. Some patients may also present with mild dysmorphic facial features, such as a broad forehead or other subtle craniofacial differences. Growth abnormalities, including short stature, and hypotonia (reduced muscle tone) have also been described in some cases. Congenital heart defects and other organ anomalies may occasionally be present, though the phenotype is highly variable, and some carriers may be mildly affected or even asymptomatic. There is currently no specific cure or targeted therapy for 14q11.2 microduplication syndrome. Management is supportive and symptom-based, typically involving early intervention programs, speech therapy, occupational therapy, physical therapy, and special educational support. Regular developmental monitoring and multidisciplinary follow-up are recommended. Genetic counseling is important for affected families, particularly because the duplication may be inherited from a mildly affected or apparently unaffected parent, or may arise de novo.

Also known as:

Clinical phenotype terms— hover any for plain English:

Exaggerated cupid's bowHP:0002263
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for 14q11.2 microduplication syndrome.

View clinical trials →

No actively recruiting trials found for 14q11.2 microduplication syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the 14q11.2 microduplication syndrome community →

No specialists are currently listed for 14q11.2 microduplication syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to 14q11.2 microduplication syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open 14q11.2 microduplication syndromeForum →

No community posts yet. Be the first to share your experience with 14q11.2 microduplication syndrome.

Start the conversation →

Latest news about 14q11.2 microduplication syndrome

No recent news articles for 14q11.2 microduplication syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about 14q11.2 microduplication syndrome

What is 14q11.2 microduplication syndrome?

14q11.2 microduplication syndrome is a rare chromosomal anomaly caused by a small duplication of genetic material on the long arm of chromosome 14 at the 11.2 band region. This condition is classified under chromosomal duplications (ICD-10: Q92.3) and is characterized by variable clinical expression, which can make diagnosis challenging. The duplicated region may encompass several genes, and the clinical consequences depend in part on the size of the duplication and the specific genes involved. The syndrome primarily affects neurodevelopmental and cognitive functions. Key clinical features re

At what age does 14q11.2 microduplication syndrome typically begin?

Typical onset of 14q11.2 microduplication syndrome is childhood. Age of onset can vary across affected individuals.